✦ LIBER ✦

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

✍ Scribed by Binder, Elisabeth B; Salyakina, Daria; Lichtner, Peter; Wochnik, Gabriele M; Ising, Marcus; Pütz, Benno; Papiol, Sergi; Seaman, Shaun; Lucae, Susanne; Kohli, Martin A

Book ID: 109919086
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 293 KB
Volume: 36
Category: Article
ISSN: 1061-4036
DOI: 10.1038/ng1479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of supporting evidence for a geneti

Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment

✍ Shih-Jen Tsai; Chen-Jee Hong; Tai-Jui Chen; Younger W-Y Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

Polymorphisms in inflammation-related ge

Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response

✍ Wong, M-L; Dong, C; Maestre-Mesa, J; Licinio, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 347 KB

Association between the 5-HT6 receptor C

Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder

✍ SEUNG-HWAN LEE; KANG-JOON LEE; HEON-JEONG LEE; BYUNG-JOO HAM; SEUNG-HO RYU; MIN- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Rapid response to paroxetine is associat

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients

✍ Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract In the present study, we investigated the relationship between the serotonin transporter gene linked polymorphic regions (5‐HTTLPR) or plasma paroxetine levels and clinical response to paroxetine in depressed patients. Sixty patients who met the DSM‐IV criteria for major depressive diso